Whitepapers

  1. Don't Let Formulation Failures Derail Drug Development 3/13/2026

    In the face of increasing molecular complexity, early developability assessment with a skilled CDMO can reduce pharmaceutical development costs, prevent clinical delays, and improve commercial success.

  2. Patented Process For Intermediates Useful For Etrasimod Arginine 3/13/2026

    Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.

  3. Patented Process For Intermediates Useful For Deucravacitinib 3/13/2026

    Discover how this patented synthetic approach to Deucravacitinib intermediates can improve yield, simplify purification, and support scalable, regulatory-aligned manufacturing.

  4. Transformative Innovation: Advancing Drug Development Using In Silico Modeling 3/4/2026

    Explore how predictive modeling and in silico strategies can turn complex data into actionable insights that accelerate drug development and reduce risk across the development lifecycle.

  5. Alleviate Compliance Risks With Your EAM/CMMS 3/2/2026

    Discover how unified asset management enhances audit readiness by connecting maintenance, calibration, and quality insights, as well as how integrated workflows reduce compliance risk.

  6. A Decade Of Transforming Pharmaceutical Manufacturing 2/25/2026

    Modern enzyme engineering, automation, and AI are reshaping therapeutic development — accelerating design, improving efficiency, and enabling faster, more sustainable biopharma manufacturing.

     

  7. Soil Testing: From Filtration To Fertilizer To Food 2/25/2026

    Soil analysis offers a clear view of the factors that influence land productivity while helping identify contaminants that could threaten safety. Understand the indicators to support sustainability decisions.

  8. How The Accelerator™ Drug Development Model Enhances eNPV 2/25/2026

    Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.

  9. Choosing The Right Platform: A Comparison For Regulated Industries 2/22/2026

    Regulated industries depend on tightly controlled review workflows, yet common tools rarely meet those demands. Explore how purpose‑built solutions strengthen compliance and help streamline timelines.

  10. Advancing ADCs With Expertise In Payloads And Linkers 2/18/2026

    Discover how integrated containment, high-potency expertise, advanced chromatography, and proven linker–payload process optimization can accelerate your ADC program from early development to reliable commercial supply.